The Claim

Cut fentanyl trafficking at the southern border by 56%.

The Claim, Unpacked

What is literally being asserted?

That fentanyl trafficking at the southern border was reduced by 56% during the first year of the Trump administration.

What is being implied but not asserted?

That the Trump administration caused this reduction. That less fentanyl is reaching American communities. That “trafficking” was directly measured (it was not; seizures were measured). That border enforcement and immigration policy are the relevant policy levers. That the “southern border” framing correctly identifies the problem as an immigration issue rather than a customs inspection issue at legal ports of entry.

What is conspicuously absent?

Any acknowledgment that fentanyl seizures and fentanyl trafficking are different things. Any disclosure that a decline in seizures could mean less trafficking, or less effective interdiction, or a shift to other routes. Any mention that 86% of fentanyl is seized at legal ports of entry, not between ports. Any mention that 81% of fentanyl smugglers at ports of entry are U.S. citizens, not unauthorized immigrants. Any context about the Sinaloa cartel civil war that disrupted Mexican production. Any mention that overdose deaths were already declining before January 2025 due to naloxone distribution, reduced precursor supply from China, and treatment expansion. Any explanation of the baseline — is 56% measured against FY2024 or FY2023?

Evidence Assessment

Established Facts

CBP fentanyl seizures at the southwest border did decline substantially in FY2025, but the math does not precisely yield 56%. CBP seized 11,486 pounds of fentanyl at the U.S.-Mexico border in FY2025, compared to 21,148 pounds in FY2024 (a 46% decline) and 26,718 pounds in FY2023 (a 57% decline). The 56% figure appears to be derived from a partial-year comparison or from comparing FY2025 to a baseline between FY2023 and FY2024. The DHS September 2025 report cited as the source noted that through January-September 2025, seizures were 55% below the same period in FY2024. The exact methodology for the “56%” has not been published. [^007-a1]

Fentanyl is overwhelmingly smuggled through legal ports of entry by U.S. citizens — not by unauthorized border crossers. CBP data shows 86% of FY2025 fentanyl seizures occurred at official ports of entry, with 5% at Border Patrol road checkpoints and 9% elsewhere in border zones. American Immigration Council FOIA data shows 81.2% of fentanyl seizure arrests at southwest border ports of entry (FY2019-June 2024) involved U.S. citizens. California and Arizona accounted for 96% of all fentanyl seizures in FY2025. This is fundamentally a customs inspection issue at legal crossing points, not a between-ports immigration enforcement issue. [^007-a2]

Overdose deaths were declining well before Trump took office, driven by multiple factors unrelated to border enforcement. CDC data shows drug overdose deaths fell 26.9% from 2023 (110,037) to 2024 (80,391). Opioid-involved deaths fell from 83,140 to 54,743 over the same period. The 12-month period ending August 2025 showed approximately 73,000 overdose deaths — a further 21% decline. This downward trend began in mid-2023, approximately 18 months before Trump’s inauguration. Experts cite naloxone availability (prescriptions surged from 6,000 in 2014 to 1.97 million in 2024), China’s late-2023 precursor chemical crackdown, declining fentanyl purity, shrinking at-risk populations, and expanded treatment access. No expert attributes the decline primarily to border policy. [^007-a3]

Fentanyl purity has been declining since 2022-2023, suggesting supply-side disruption that predates the Trump administration. DEA’s 2025 National Drug Threat Assessment reports average fentanyl powder purity fell from 19.2-19.5% in FY2024 to 10.3-11.36% in FY2025. Only 29% of fentanyl pills contained a potentially lethal dose (2mg+) in FY2025, down from 76% in FY2023. This purity decline is attributed primarily to disrupted precursor chemical supply from China and Sinaloa cartel internal warfare, not to U.S. border enforcement. [^007-a4]

Strong Inferences

The 56% figure conflates seizures with trafficking — a fundamental measurement error. Seizure data tells you how much fentanyl was caught, not how much was trafficked. A decline in seizures can mean: (a) less fentanyl was trafficked, (b) the same amount was trafficked but through routes or methods that evade detection, (c) interdiction became less effective, or (d) some combination. DHS itself estimates it intercepts only about 3% of cocaine at ports of entry, providing a rough analogue for interdiction rates. Without data on total trafficking volume — which by definition is unknowable for illicit markets — seizure data alone cannot establish a “56% cut in trafficking.” The claim states a conclusion that its own evidence cannot support. [^007-a5]

The Sinaloa cartel civil war, not U.S. border policy, is likely the primary driver of reduced Mexican fentanyl production. Following the arrest of Ismael “El Mayo” Zambada in June 2024, a violent factional war erupted between Los Chapitos and Los Mayos within the Sinaloa cartel. Over 600-1,000 people died in Sinaloa state from this conflict. Reports indicate a faction-ordered pause in fentanyl production during the conflict. This disruption correlates with the timing of declining seizures far more precisely than any U.S. policy change. [^007-a6]

China’s precursor chemical regulations, initiated under the Biden administration, contributed to reduced fentanyl supply. In August 2024 (under Biden), Chinese authorities added key precursor chemicals (4-AP, 1-boc-4-AP, norfentanyl) to their controlled list. In November 2025, China placed export controls on 13 precursor chemicals shipped to North America. A January 2026 Science journal study found fentanyl became less available in the U.S. starting in 2023. Peter Reuter (University of Maryland) stated: “It’s very likely that (the change in purity) has something to do with precursor supply.” However, the State Department’s March 2025 report noted China’s enforcement “remains uneven and opaque.” [^007-a7]

The administration faces an inherent logical contradiction in its seizure messaging. Under Biden, when fentanyl seizures increased, administration critics (including Trump) cited rising seizures as evidence of policy failure — more drugs getting through. Under Trump, when seizures decreased, the administration cites declining seizures as evidence of policy success — less drugs getting through. Both claims cannot be simultaneously valid. Either more seizures are good (meaning better interdiction) or fewer seizures are good (meaning less trafficking) — but the interpretation shifts to suit the political narrative. [^007-a8]

Informed Speculation

The claim’s placement in the “SECURING AMERICA’S BORDERS” section, and its reference to the “southern border,” frames fentanyl trafficking as an immigration and border security issue. This framing is strategically useful: it justifies the administration’s broader border enforcement apparatus by linking it to the fentanyl crisis, which enjoys bipartisan public concern. But the evidence shows that fentanyl smuggling is overwhelmingly a legal port-of-entry, U.S.-citizen-driven customs enforcement challenge — not a between-ports immigration enforcement problem. The claim implicitly connects fentanyl to unauthorized immigration, when the data shows these are largely separate phenomena.

The decline in fentanyl availability is real and welcome. But attributing it to “cutting fentanyl trafficking at the southern border” implies causation from border enforcement when the more plausible causal chain runs: (1) China’s precursor regulations reduced raw material supply, (2) the Sinaloa cartel’s internal war disrupted production, (3) declining purity and availability reduced demand-side exposure, and (4) naloxone and treatment expansion reduced deaths among those still using. U.S. border enforcement exists in this picture but is downstream of the primary causal factors.

Structural Analysis

Seizures are not trafficking (the measurement problem). This is the foundational issue. The claim says “trafficking” but measures “seizures.” These are profoundly different metrics. If I tell you police recovered 46% fewer stolen cars this year, you cannot conclude that car theft fell 46%. It might have fallen, or police might be solving fewer cases, or thieves might be better at hiding. The same logic applies to drug seizures. The claim presents a measurement it can make (seizures) as if it were a measurement it cannot make (trafficking).

Cui bono. The fentanyl crisis commands broad public sympathy. By claiming credit for reduced fentanyl trafficking, the administration connects its border enforcement narrative to the one drug issue that crosses partisan lines. This framing justifies border wall spending, expanded CBP authority, and immigration restrictions by linking them to fentanyl — even though fentanyl enters primarily through legal ports carried by citizens.

The attribution problem. Even if we accept that less fentanyl crossed the border in FY2025 (which the seizure decline suggests but does not prove), the question is why. The evidence points to a convergence of factors: China’s precursor crackdown (initiated under Biden), cartel civil war in Sinaloa (June 2024, before Trump’s inauguration), declining fentanyl purity (trend beginning 2022-2023), and expanded scanning technology at ports of entry (multi-administration investment). The claim attributes the entire reduction to the Trump administration without acknowledging any of these factors.

Follow the money. Fentanyl is extremely cheap to produce (precursor chemicals costing thousands of dollars yield millions of dollars in retail product). Even with reduced purity and seizures, the economic incentive for production remains enormous. As the DEA’s own threat assessment notes, producers are adapting — substituting restricted precursors with “less restricted, easier-to-obtain chemicals” and designer precursors. Supply-side disruption in illegal drug markets has historically been temporary.

Context the Framing Omits

Fentanyl enters through legal ports of entry, not the desert. Eighty-six percent of fentanyl is seized at official border crossings, carried primarily in vehicles. Only 5% is seized by Border Patrol at road checkpoints and 9% elsewhere. The “southern border” framing implies a border-wall-and-patrol problem. The data describes a customs-inspection-at-legal-crossings problem.

U.S. citizens, not immigrants, are the primary smugglers. Eighty-one percent of fentanyl seizure arrests at southwest border ports of entry involve U.S. citizens. Fentanyl trafficking is not primarily an immigration issue — it is a domestic criminal enterprise that recruits American citizens to drive drugs through legal ports.

The overdose death decline began 18 months before inauguration. CDC provisional data shows overdose deaths peaked in 2022 (~110,000) and have been declining since mid-2023. By the time Trump took office in January 2025, deaths had already fallen to approximately 80,000 (a 27% decline). The multi-factor causes — naloxone availability, treatment access, precursor regulation, declining purity — all predate the current administration.

The Sinaloa cartel civil war disrupted production. El Mayo Zambada’s arrest in June 2024 triggered factional warfare that killed hundreds and disrupted cartel operations including fentanyl lab production. This supply-side shock aligns more precisely with the seizure decline timeline than any U.S. policy change.

China’s precursor regulations were a Biden-era achievement. The diplomatic pressure that led to China’s August 2024 and November 2025 precursor chemical controls began under the Biden administration, including at the November 2023 Biden-Xi summit in San Francisco.

Reduced seizures could mean less effective interdiction. If cartels shifted to new routes, methods, or smuggling networks that evade detection, seizures would fall even if trafficking remained constant or increased. Without total flow estimates — which no one has — the seizure data is ambiguous.

Despite declining seizures, fentanyl remains widely available. The DEA’s 2025 National Drug Threat Assessment describes persistent street-level availability. Law enforcement reports “ready availability of low-priced fentanyl” despite announced enforcement actions. The emergence of adulterants like xylazine and medetomidine in the fentanyl supply suggests an active, adapting market — not a disrupted one.

Verdict

Factual core: The seizure data is real — CBP fentanyl seizures at the southwest border fell approximately 46% from FY2024 and 57% from FY2023. The exact “56%” figure appears cherry-picked from a partial-year comparison, but a substantial decline in seizures is documented.

The word “trafficking” makes the claim misleading. Seizures are not trafficking. The claim states that trafficking was “cut by 56%” — a causal assertion about the total flow of fentanyl — based on seizure data that measures only what was caught. This is like measuring the fish you caught and declaring the ocean has fewer fish.

Attribution is the central flaw. Even accepting that less fentanyl crossed the border (which is plausible but unproven), the causal factors include China’s precursor regulations (Biden-era diplomacy), the Sinaloa cartel’s civil war (a Mexican event), declining fentanyl purity (a trend beginning in 2022-2023), and expanded scanning technology (multi-administration investment). The claim attributes a multi-causal outcome entirely to the Trump administration.

The immigration framing is factually wrong. Fentanyl enters primarily through legal ports of entry (86%), carried by U.S. citizens (81%). Placing this claim in the “SECURING AMERICA’S BORDERS” section, among immigration enforcement claims, implies fentanyl trafficking is an immigration problem. It is not.

Framing as “win”: Misleading. The decline in fentanyl seizures is real and likely reflects some genuine reduction in trafficking. Overdose deaths are declining — a genuinely positive trend. But the attribution to this administration’s border policies is unsupported by the evidence. The most accurate statement would be: “Fentanyl seizures at the southwest border fell approximately 46% from the prior year and 57% from the 2023 peak, reflecting a combination of Chinese precursor regulations, Mexican cartel disruption, declining purity, and enhanced port-of-entry scanning. The administration’s immigration enforcement policies are largely unrelated, since 86% of fentanyl enters through legal ports carried by U.S. citizens.”

What a reader should understand: Fentanyl seizures at the southwest border did fall significantly in FY2025 — that is a real and documented fact. But “seizures” and “trafficking” are not the same thing, and the decline has multiple causes that largely predate and are external to the Trump administration: China’s precursor crackdown, the Sinaloa cartel civil war, declining fentanyl purity since 2022, and expanded naloxone availability. Most critically, fentanyl enters the U.S. primarily through legal ports of entry carried by American citizens — making it a customs enforcement issue, not the immigration enforcement issue this claim’s placement implies.

Cross-References

• Item #6: “Reduced illegal border crossings to their lowest level since the 1970s” — same geographic context; shares the seizure-vs-reality analytical problem
• Item #8: “Ended catch-and-release” — related enforcement posture; the zero-release policy would not affect fentanyl smuggling through ports of entry by U.S. citizens
• Item #10: “Declared a national border emergency” — the emergency declaration cited as enabling the response, but fentanyl enters through legal crossings

Sources

WOLA. “Weekly U.S.-Mexico Border Update: Drug Seizure Data.” November 2025. https://www.wola.org/2025/11/weekly-u-s-mexico-border-update-drug-seizure-data-pope-leo-voices-concern-updates-from-the-americas/

Reason. “5 Reasons to Doubt Trump’s Boast About Bringing Down Fentanyl Smuggling.” February 24, 2026. https://reason.com/2026/02/24/5-reasons-to-doubt-trumps-boast-about-bringing-down-fentanyl-smuggling/

FactCheck.org. “Illegal Immigration and Fentanyl at the U.S. Northern and Southwest Borders.” January 2025. https://www.factcheck.org/2025/01/illegal-immigration-and-fentanyl-at-the-u-s-northern-and-southwest-borders/

American Immigration Council. “Fentanyl Smuggling: Most Seizures Occur at Ports of Entry Where U.S. Citizens Are the Primary Smugglers.” July 2025. https://www.americanimmigrationcouncil.org/fact-sheet/fentanyl-smuggling/

CDC NCHS. “U.S. Overdose Deaths Decrease Almost 27% in 2024.” May 14, 2025. https://www.cdc.gov/nchs/pressroom/releases/20250514.html

STAT News. “U.S. Overdose Deaths Fell Through Most of 2025, CDC Data Says.” January 14, 2026. https://www.statnews.com/2026/01/14/us-overdose-deaths-fell-through-most-of-2025/

DEA. “DEA Releases 2025 National Drug Threat Assessment.” May 15, 2025. https://www.dea.gov/press-releases/2025/05/15/dea-releases-2025-national-drug-threat-assessment

PolitiFact. “What’s Driving Down US Overdose Deaths? Experts Cite Drug Supply Changes, Increased Naloxone.” January 29, 2026. https://www.politifact.com/article/2026/jan/29/drug-overdose-deaths-decline-naloxone-treatment/

USAFacts. “How Much Fentanyl Is Seized at US Borders Each Month?” 2026. https://usafacts.org/answers/how-much-fentanyl-is-seized-at-us-borders/country/united-states/

DHS. “CBP Reports that Drug Seizures Surge Again in August.” September 30, 2025. https://www.dhs.gov/news/2025/09/30/cbp-reports-drug-seizures-surge-again-august

CBP. “One Year of the Most Secure Border in History.” January 20, 2026. https://www.cbp.gov/newsroom/national-media-release/one-year-most-secure-border-history

White House. “President Trump Is Securing Our Homeland: Ending the Invasion, Deporting Criminals, and Protecting Our Communities.” February 2026. https://www.whitehouse.gov/articles/2026/02/president-trump-is-securing-our-homeland-ending-the-invasion-deporting-criminals-and-protecting-our-communities/

Wilson Center. “Fentanyl Seizures at the Southwest Border: A Breakdown by CBP Areas of Responsibility.” https://www.wilsoncenter.org/article/fentanyl-seizures-southwest-border-breakdown-cbp-areas-responsibility